Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6EN4

SF3b core in complex with a splicing modulator

Summary for 6EN4
Entry DOI10.2210/pdb6en4/pdb
Related5IFE
DescriptorSplicing factor 3B subunit 3, Splicing factor 3B subunit 5, Splicing factor 3B subunit 1, ... (6 entities in total)
Functional Keywordsprotein complex, splicing modulator, splicing
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains4
Total formula weight254056.34
Authors
Cretu, C.,Pena, V. (deposition date: 2017-10-04, release date: 2018-06-20, Last modification date: 2024-01-17)
Primary citationCretu, C.,Agrawal, A.A.,Cook, A.,Will, C.L.,Fekkes, P.,Smith, P.G.,Luhrmann, R.,Larsen, N.,Buonamici, S.,Pena, V.
Structural Basis of Splicing Modulation by Antitumor Macrolide Compounds.
Mol. Cell, 70:265-273.e8, 2018
Cited by
PubMed Abstract: SF3B is a multi-protein complex essential for branch site (BS) recognition and selection during pre-mRNA splicing. Several splicing modulators with antitumor activity bind SF3B and thereby modulate splicing. Here we report the crystal structure of a human SF3B core in complex with pladienolide B (PB), a macrocyclic splicing modulator and potent inhibitor of tumor cell proliferation. PB stalls SF3B in an open conformation by acting like a wedge within a hinge, modulating SF3B's transition to the closed conformation needed to form the BS adenosine-binding pocket and stably accommodate the BS/U2 duplex. This work explains the structural basis for the splicing modulation activity of PB and related compounds, and reveals key interactions between SF3B and a common pharmacophore, providing a framework for future structure-based drug design.
PubMed: 29656923
DOI: 10.1016/j.molcel.2018.03.011
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.08 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon